MUCOPOLYSACCHARIDOSIS IIIA

Clinical trials for MUCOPOLYSACCHARIDOSIS IIIA explained in plain language.

Never miss a new study

Get alerted when new MUCOPOLYSACCHARIDOSIS IIIA trials appear

Sign up with your email to follow new studies for MUCOPOLYSACCHARIDOSIS IIIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Gene therapy for rare childhood brain disease: tracking kids for years after treatment

Disease control ENROLLING_BY_INVITATION

This study is tracking children with Sanfilippo Syndrome A (MPS IIIA) who received an experimental gene therapy called UX111 in earlier trials. The goal is to monitor their long-term safety and see how well the treatment continues to work over many years. Researchers will check f…

Matched conditions: MUCOPOLYSACCHARIDOSIS IIIA

Phase: PHASE3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

MUCOPOLYSACCHARIDOSIS IIIA

Get alerted when new MUCOPOLYSACCHARIDOSIS IIIA trials appear

Gene therapy for rare childhood brain disease: tracking kids for years after treatment